|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Collaboration revenue | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Gain on lease modification | |||||
| Impairment of long-lived assets | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income, net: | |||||
| Interest income | |||||
| Other income, net | |||||
| Total other income, net | |||||
| Loss before income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Other comprehensive gain (loss): | |||||
| Unrealized gains (losses) on marketable securities | |||||
| Total other comprehensive gain (loss) | |||||
| Total comprehensive loss | |||||
| Net loss per share attributable to common stockholders—basic (in dollars per share) | |||||
| Net loss per share attributable to common stockholders—diluted (in dollars per share) | |||||
| Weighted average common shares outstanding—basic (in shares) | |||||
| Weighted average common shares outstanding—diluted (in shares) | |||||
Loading...